Type IIb hyperlipoproteinaemia

Also known as: Type IIb Hypercholesterolemia / Hyperlipoproteinemia Type IIb / Type IIb hyperlipoproteinemia / Mixed hyperlipidemia / Fredrickson Type IIb hyperlipoproteinaemia / Fredrickson Type IIb hyperlipoproteinemia / Familial combined hyperlipidemia (disorder) / Familial defective apolipoprotein B-100 (disorder) / Other hyperlipidemia / Type IIb hyperlipidaemia / Type IIb hyperlipidemia / Familial multiple lipoprotein-type hyperlipidemia (disorder) / Hyperlipidemia, Familial Combined

Drug	Drug Name	Drug Description
DB01393	Bezafibrate	A lipid-lowering fibrate used in the management of primary and secondary hyperlipidaemia, when there is a lack of clinical improvement following lifestyle modifications or correction of the underlying disorder.

Drug	Drug Name	Target	Type
DB01393	Bezafibrate	Peroxisome proliferator-activated receptor alpha	target
DB01393	Bezafibrate	Solute carrier organic anion transporter family member 1B1	transporter
DB01393	Bezafibrate	Peroxisome proliferator-activated receptor delta	target
DB01393	Bezafibrate	Peroxisome proliferator-activated receptor gamma	target
DB01393	Bezafibrate	Cytochrome P450 1A1	enzyme
DB01393	Bezafibrate	Cytochrome P450 2C8	enzyme
DB01393	Bezafibrate	Cytochrome P450 3A4	enzyme
DB01393	Bezafibrate	Nuclear receptor subfamily 1 group I member 2	target
DB01393	Bezafibrate	Retinoic acid receptor RXR-alpha	target
DB01393	Bezafibrate	Retinoic acid receptor RXR-beta	target
DB01393	Bezafibrate	Retinoic acid receptor RXR-gamma	target

Drug	Drug Name	Phase	Status	Count
DB01098	Rosuvastatin	4	Completed	1